A blood test combining PSA and other protein markers, genetic risk factors and clinical data, used to help assess risk of clinically significant prostate cancer.
1 biomarker as listed by Better2Know.
Stockholm3 is an algorithm-based blood test aimed at assessing the risk of clinically significant prostate cancer. According to the provider, it combines PSA with additional protein markers such as free PSA, PSP94, GDF15 and KLK2, alongside genetic risk markers and clinical factors including age, family history and previous biopsy results, to produce a personalised risk assessment rather than relying on a PSA reading alone.
We have no other men's health tests logged in our data to compare this one against directly. In our system it is recorded as a single combined marker, which is part of why it scores modestly for clinical depth despite the number of components the provider describes feeding into the result. Those components are described in the provider's own text rather than itemised in the structured data we score against. At £595, it also sits well above the typical price for similarly sized men's health tests we track.
The scores reflect the longer 14-day turnaround this test needs, results that are not doctor-reviewed as standard, and a price that is high relative to other men's health tests, set against a clearly documented listing. Trust reflects Better2Know's Trustpilot rating of 4.2 from 775 reviews, CQC registration and 18 years trading.
This may suit a man aged 45 or over, or one with a family history of prostate cancer or a previous raised PSA, who wants a risk assessment that looks beyond PSA alone. It is not a substitute for discussing symptoms with a doctor. We have no comparable men's health tests in our data for this one, so we cannot confirm whether an equivalent test is available more cheaply elsewhere. The 14-day turnaround is also longer than most single-marker tests in our data, so it will not suit anyone wanting a quick result.
A trained professional takes a standard venous blood sample at a Better2Know clinic. The sample is analysed alongside genetic markers and the clinical information you provide, such as age and family history. Results are reported within around 14 days and are uploaded to your online patient area. They are not doctor-reviewed as standard.
Stockholm3 combines PSA with additional protein markers, genetic risk factors and clinical data such as age and family history to give a risk score for clinically significant prostate cancer, for £595. We have no comparable men's health tests in our data to benchmark this against by name, though the price sits well above the median for similarly sized tests in that category. Results take around 14 days and are not doctor-reviewed as standard.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 23rd percentile of mens health tests we track.
Requires a venous draw at a clinic; a home nurse visit is offered; results in around 14 days, slower than similar tests.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.
£595.00 against a median of £62.00 for the 12 similarly sized mens health tests we track (+860%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
One of the deepest men's health panels we track
A 21-marker blood test covering testosterone, cholesterol, liver health, inflammation and vitamin D, for men wanting a broad check on long-term health risk.
50-marker hormone and inflammation panel for skin concerns
A 50-marker blood panel covering hormones, thyroid, inflammation, iron, liver, kidney and vitamin levels that can influence skin condition. Suited to anyone investigating persistent skin issues such as breakouts or dryness.
PSA test priced at the group's £59 median
A single blood test measuring prostate specific antigen (PSA), a marker commonly used to help assess prostate cancer risk. Suited to men aged 45 and over, or 40 and over if at higher risk, as part of regular monitoring.
Cheaper than most PSA tests we track, but not the cheapest
Measures PSA, a protein produced by the prostate, commonly used to assess prostate health. Suited to those in a higher-risk group by age, ethnicity or family history.
